Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on ATP Regeneration. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115927507A reveals a novel enzymatic route for oligosaccharides. Achieve significant cost reduction in pharmaceutical intermediates manufacturing via ATP regeneration.
Patent CN102978267B reveals advanced enzymatic glutathione production with ATP regeneration. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN109851658B reveals one-step L-carnosine synthesis reducing cost and improving supply chain reliability for pharmaceutical intermediates.